Can people with diabetes take Mounjaro for weight loss?

You have type 2 diabetes and your doctor mentioned Mounjaro, here is what that means in practice

Imagine you have been managing type 2 diabetes for a few years: metformin on the repeat prescription, weight that has crept up, and a GP who has just mentioned tirzepatide. That is one of the most common scenarios our prescribers encounter. Mounjaro works as a dual GIP and GLP-1 receptor agonist, activating two gut-hormone pathways that regulate both appetite and blood-sugar response. Because of that dual action, it has been studied and licensed in the UK specifically for type 2 diabetes, as well as for weight management in adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition. The NHS patient information for tirzepatide sets out both indications clearly.

In practice, if you have type 2 diabetes and meet the BMI threshold, a single prescription can address both. The prescriber's job is to look at the full picture: your current diabetes medicines, your kidney function, your HbA1c, and any other conditions. That assessment is not a box-ticking exercise. It shapes the starting dose and the monitoring plan that comes with it.

One misconception worth laying to rest gently: some people assume that because Mounjaro lowers blood sugar it must be 'dangerous' for people who already take diabetes medication. The reality is more nuanced. The risk, where it exists, comes from combining tirzepatide with insulin or a sulphonylurea, those combinations can push glucose too low. A prescriber who knows your medicines will adjust doses before you start, not after. Our clinical team reviews every consultation individually for exactly this reason.

Type 1 diabetes and Mounjaro: a different and more cautious conversation

Type 1 diabetes is where the picture changes significantly. Tirzepatide does not replace insulin; people with type 1 depend on insulin for survival, and the mechanisms that make tirzepatide effective in type 2 do not translate directly. Mounjaro is not licensed for type 1 diabetes in the UK, and the clinical evidence in this population is limited compared with the large SURMOUNT trials that underpinned the weight-management licence.

That does not mean the conversation is completely closed, some specialists in diabetes centres do explore it in carefully selected patients with obesity and type 1, under close monitoring. But that is a decision for a consultant diabetologist, not an online weight-loss service. Our prescribers would not prescribe Mounjaro to someone with type 1 diabetes through a private weight-management route; the appropriate place for that discussion is your specialist team. If you want to understand the nuance further, and particularly whether a type 1 diabetic can take Mounjaro and what the clinical reasoning involves, that detail is covered there alongside guidance on what to ask your consultant.

There is also a separate question about tirzepatide specifically in type 1 settings (the licensing position and any emerging data) which we address there rather than compressing it here.

What your prescriber will want to know before approving treatment

Whether you are applying through a private service like ours or asking your GP, expect the prescriber to ask about more than your BMI. For anyone with diabetes, the key questions are: what type, how long, what medicines, and what your recent blood-sugar control looks like. The NICE appraisal of tirzepatide (TA1026) sets out the eligibility framework for weight management; your diabetes history shapes how that framework applies to you.

Kidney function matters too. Mounjaro is not recommended if your eGFR falls below a certain threshold, and because some diabetes medications are also renally cleared, your prescriber needs the full list. If you take medicines for blood pressure alongside diabetes drugs, those matter as well, not to disqualify you, but to ensure the plan is safe from day one.

At nume, the consultation is reviewed the same day by a GPhC-registered Independent Prescriber. A real clinician reads your answers; our Mounjaro for diabetics page explains the process in more detail, including what documentation helps if you are already on diabetes treatment. If approved and you order before 12pm Monday to Friday, your treatment is dispatched the same day and delivered free the next working day by DPD. Transfer patients and those requesting dose increases provide evidence of their current treatment as part of the clinical review, that check protects you.

If you are unsure whether your situation fits, the safest starting point is the free consultation. You can also read about whether Mounjaro is suitable for diabetics more broadly, or explore all the weight-loss treatments we offer to see where tirzepatide sits among the options. Our FAQs also answer many of the practical questions that come up after an initial assessment.